nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupropion—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.403	1	CbGbCtD
Bupropion—Hypoaesthesia oral—Riluzole—amyotrophic lateral sclerosis	0.0124	0.0232	CcSEcCtD
Bupropion—Hyperacusis—Riluzole—amyotrophic lateral sclerosis	0.00869	0.0163	CcSEcCtD
Bupropion—Dental caries—Riluzole—amyotrophic lateral sclerosis	0.00869	0.0163	CcSEcCtD
Bupropion—Manic psychosis—Riluzole—amyotrophic lateral sclerosis	0.00819	0.0153	CcSEcCtD
Bupropion—Yawning—Riluzole—amyotrophic lateral sclerosis	0.00804	0.0151	CcSEcCtD
Bupropion—Paranoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00761	0.0143	CcSEcCtD
Bupropion—Paraesthesia oral—Riluzole—amyotrophic lateral sclerosis	0.0069	0.0129	CcSEcCtD
Bupropion—Muscle relaxant therapy—Riluzole—amyotrophic lateral sclerosis	0.00651	0.0122	CcSEcCtD
Bupropion—Hypotonia—Riluzole—amyotrophic lateral sclerosis	0.00616	0.0115	CcSEcCtD
Bupropion—Renal pain—Riluzole—amyotrophic lateral sclerosis	0.00616	0.0115	CcSEcCtD
Bupropion—Vulvovaginal mycotic infection—Riluzole—amyotrophic lateral sclerosis	0.00592	0.0111	CcSEcCtD
Bupropion—Hostility—Riluzole—amyotrophic lateral sclerosis	0.00585	0.011	CcSEcCtD
Bupropion—Osteoporosis—Riluzole—amyotrophic lateral sclerosis	0.00577	0.0108	CcSEcCtD
Bupropion—Micturition urgency—Riluzole—amyotrophic lateral sclerosis	0.0057	0.0107	CcSEcCtD
Bupropion—Gingival bleeding—Riluzole—amyotrophic lateral sclerosis	0.0057	0.0107	CcSEcCtD
Bupropion—Suicide attempt—Riluzole—amyotrophic lateral sclerosis	0.0057	0.0107	CcSEcCtD
Bupropion—Gastric ulcer—Riluzole—amyotrophic lateral sclerosis	0.00557	0.0104	CcSEcCtD
Bupropion—Completed suicide—Riluzole—amyotrophic lateral sclerosis	0.0055	0.0103	CcSEcCtD
Bupropion—Myoclonus—Riluzole—amyotrophic lateral sclerosis	0.00538	0.0101	CcSEcCtD
Bupropion—Polyp—Riluzole—amyotrophic lateral sclerosis	0.00532	0.00997	CcSEcCtD
Bupropion—Libido increased—Riluzole—amyotrophic lateral sclerosis	0.00532	0.00997	CcSEcCtD
Bupropion—Tooth disorder—Riluzole—amyotrophic lateral sclerosis	0.00499	0.00935	CcSEcCtD
Bupropion—Supraventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00494	0.00925	CcSEcCtD
Bupropion—Upset stomach—Riluzole—amyotrophic lateral sclerosis	0.00494	0.00925	CcSEcCtD
Bupropion—Cyst—Riluzole—amyotrophic lateral sclerosis	0.00484	0.00907	CcSEcCtD
Bupropion—Hypokinesia—Riluzole—amyotrophic lateral sclerosis	0.00479	0.00898	CcSEcCtD
Bupropion—Paranoia—Riluzole—amyotrophic lateral sclerosis	0.00475	0.0089	CcSEcCtD
Bupropion—Hyperventilation—Riluzole—amyotrophic lateral sclerosis	0.0047	0.00881	CcSEcCtD
Bupropion—Depersonalisation—Riluzole—amyotrophic lateral sclerosis	0.00462	0.00865	CcSEcCtD
Bupropion—Delusion—Riluzole—amyotrophic lateral sclerosis	0.00457	0.00857	CcSEcCtD
Bupropion—Apathy—Riluzole—amyotrophic lateral sclerosis	0.00453	0.00849	CcSEcCtD
Bupropion—Metrorrhagia—Riluzole—amyotrophic lateral sclerosis	0.00453	0.00849	CcSEcCtD
Bupropion—Laryngitis—Riluzole—amyotrophic lateral sclerosis	0.00449	0.00841	CcSEcCtD
Bupropion—Flat affect—Riluzole—amyotrophic lateral sclerosis	0.00449	0.00841	CcSEcCtD
Bupropion—Mania—Riluzole—amyotrophic lateral sclerosis	0.00445	0.00834	CcSEcCtD
Bupropion—Extrapyramidal disorder—Riluzole—amyotrophic lateral sclerosis	0.0043	0.00805	CcSEcCtD
Bupropion—Amblyopia—Riluzole—amyotrophic lateral sclerosis	0.00419	0.00785	CcSEcCtD
Bupropion—Glycosuria—Riluzole—amyotrophic lateral sclerosis	0.004	0.00748	CcSEcCtD
Bupropion—Liver injury—Riluzole—amyotrophic lateral sclerosis	0.00385	0.00721	CcSEcCtD
Bupropion—Delirium—Riluzole—amyotrophic lateral sclerosis	0.00376	0.00705	CcSEcCtD
Bupropion—Amenorrhoea—Riluzole—amyotrophic lateral sclerosis	0.00368	0.0069	CcSEcCtD
Bupropion—Accidental injury—Riluzole—amyotrophic lateral sclerosis	0.00366	0.00685	CcSEcCtD
Bupropion—Musculoskeletal stiffness—Riluzole—amyotrophic lateral sclerosis	0.00361	0.00676	CcSEcCtD
Bupropion—Cough increased—Riluzole—amyotrophic lateral sclerosis	0.00354	0.00662	CcSEcCtD
Bupropion—Thinking abnormal—Riluzole—amyotrophic lateral sclerosis	0.00354	0.00662	CcSEcCtD
Bupropion—Glossitis—Riluzole—amyotrophic lateral sclerosis	0.00351	0.00658	CcSEcCtD
Bupropion—Nocturia—Riluzole—amyotrophic lateral sclerosis	0.00349	0.00654	CcSEcCtD
Bupropion—Leukocytosis—Riluzole—amyotrophic lateral sclerosis	0.00344	0.00645	CcSEcCtD
Bupropion—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.00342	0.00641	CcSEcCtD
Bupropion—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.00342	0.00641	CcSEcCtD
Bupropion—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.0033	0.00617	CcSEcCtD
Bupropion—Neck pain—Riluzole—amyotrophic lateral sclerosis	0.00328	0.00614	CcSEcCtD
Bupropion—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.00324	0.00606	CcSEcCtD
Bupropion—Hepatocellular injury—Riluzole—amyotrophic lateral sclerosis	0.00324	0.00606	CcSEcCtD
Bupropion—Abnormal dreams—Riluzole—amyotrophic lateral sclerosis	0.0032	0.00599	CcSEcCtD
Bupropion—SLC6A3—nerve—amyotrophic lateral sclerosis	0.00315	0.098	CbGeAlD
Bupropion—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00313	0.00586	CcSEcCtD
Bupropion—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.00313	0.00586	CcSEcCtD
Bupropion—Photophobia—Riluzole—amyotrophic lateral sclerosis	0.00304	0.00569	CcSEcCtD
Bupropion—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.00297	0.00557	CcSEcCtD
Bupropion—Coma—Riluzole—amyotrophic lateral sclerosis	0.00296	0.00554	CcSEcCtD
Bupropion—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.00293	0.00548	CcSEcCtD
Bupropion—Neoplasm—Riluzole—amyotrophic lateral sclerosis	0.00293	0.00548	CcSEcCtD
Bupropion—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.00284	0.00532	CcSEcCtD
Bupropion—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.00281	0.00526	CcSEcCtD
Bupropion—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.00278	0.00521	CcSEcCtD
Bupropion—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.00275	0.00516	CcSEcCtD
Bupropion—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.00275	0.00516	CcSEcCtD
Bupropion—Phlebitis—Riluzole—amyotrophic lateral sclerosis	0.00273	0.00511	CcSEcCtD
Bupropion—Hepatic function abnormal—Riluzole—amyotrophic lateral sclerosis	0.00269	0.00504	CcSEcCtD
Bupropion—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.00268	0.00501	CcSEcCtD
Bupropion—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00263	0.00492	CcSEcCtD
Bupropion—Eczema—Riluzole—amyotrophic lateral sclerosis	0.00261	0.0049	CcSEcCtD
Bupropion—Injury—Riluzole—amyotrophic lateral sclerosis	0.00256	0.00479	CcSEcCtD
Bupropion—SLC6A2—nerve—amyotrophic lateral sclerosis	0.00254	0.0791	CbGeAlD
Bupropion—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.00253	0.00475	CcSEcCtD
Bupropion—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.0025	0.00468	CcSEcCtD
Bupropion—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.0025	0.00468	CcSEcCtD
Bupropion—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.00249	0.00466	CcSEcCtD
Bupropion—Thirst—Riluzole—amyotrophic lateral sclerosis	0.00247	0.00463	CcSEcCtD
Bupropion—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00242	0.00453	CcSEcCtD
Bupropion—SLC6A3—hindbrain—amyotrophic lateral sclerosis	0.00236	0.0734	CbGeAlD
Bupropion—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00235	0.0044	CcSEcCtD
Bupropion—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00235	0.0044	CcSEcCtD
Bupropion—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00235	0.0044	CcSEcCtD
Bupropion—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00233	0.00437	CcSEcCtD
Bupropion—Migraine—Riluzole—amyotrophic lateral sclerosis	0.00231	0.00433	CcSEcCtD
Bupropion—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.00231	0.00433	CcSEcCtD
Bupropion—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00229	0.0043	CcSEcCtD
Bupropion—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.00227	0.00425	CcSEcCtD
Bupropion—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00223	0.00419	CcSEcCtD
Bupropion—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.00223	0.00417	CcSEcCtD
Bupropion—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00221	0.00414	CcSEcCtD
Bupropion—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.00219	0.00409	CcSEcCtD
Bupropion—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.00215	0.00402	CcSEcCtD
Bupropion—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.00212	0.00398	CcSEcCtD
Bupropion—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00208	0.0039	CcSEcCtD
Bupropion—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00207	0.00388	CcSEcCtD
Bupropion—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00204	0.00383	CcSEcCtD
Bupropion—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00203	0.0038	CcSEcCtD
Bupropion—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00203	0.0038	CcSEcCtD
Bupropion—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00203	0.0038	CcSEcCtD
Bupropion—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00199	0.00373	CcSEcCtD
Bupropion—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00195	0.00366	CcSEcCtD
Bupropion—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00195	0.00365	CcSEcCtD
Bupropion—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00193	0.00361	CcSEcCtD
Bupropion—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.0019	0.00356	CcSEcCtD
Bupropion—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.00188	0.00351	CcSEcCtD
Bupropion—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00187	0.0035	CcSEcCtD
Bupropion—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00185	0.00347	CcSEcCtD
Bupropion—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00185	0.00346	CcSEcCtD
Bupropion—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.00184	0.00344	CcSEcCtD
Bupropion—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00182	0.00341	CcSEcCtD
Bupropion—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00181	0.00339	CcSEcCtD
Bupropion—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00181	0.00339	CcSEcCtD
Bupropion—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.00178	0.00334	CcSEcCtD
Bupropion—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00332	CcSEcCtD
Bupropion—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00332	CcSEcCtD
Bupropion—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00176	0.00331	CcSEcCtD
Bupropion—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00176	0.00331	CcSEcCtD
Bupropion—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00176	0.0033	CcSEcCtD
Bupropion—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00174	0.00325	CcSEcCtD
Bupropion—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.00171	0.0032	CcSEcCtD
Bupropion—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.0017	0.00318	CcSEcCtD
Bupropion—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00306	CcSEcCtD
Bupropion—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00305	CcSEcCtD
Bupropion—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00305	CcSEcCtD
Bupropion—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00305	CcSEcCtD
Bupropion—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.00162	0.00303	CcSEcCtD
Bupropion—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00162	0.00303	CcSEcCtD
Bupropion—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00161	0.00302	CcSEcCtD
Bupropion—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00161	0.00301	CcSEcCtD
Bupropion—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.0016	0.003	CcSEcCtD
Bupropion—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.0016	0.00299	CcSEcCtD
Bupropion—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00159	0.00298	CcSEcCtD
Bupropion—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00154	0.00288	CcSEcCtD
Bupropion—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00152	0.00285	CcSEcCtD
Bupropion—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00151	0.00283	CcSEcCtD
Bupropion—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00147	0.00276	CcSEcCtD
Bupropion—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00147	0.00275	CcSEcCtD
Bupropion—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00146	0.00274	CcSEcCtD
Bupropion—Chills—Riluzole—amyotrophic lateral sclerosis	0.00146	0.00273	CcSEcCtD
Bupropion—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00145	0.00272	CcSEcCtD
Bupropion—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00144	0.00269	CcSEcCtD
Bupropion—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00142	0.00267	CcSEcCtD
Bupropion—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00141	0.00265	CcSEcCtD
Bupropion—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00139	0.00261	CcSEcCtD
Bupropion—Tension—Riluzole—amyotrophic lateral sclerosis	0.00139	0.0026	CcSEcCtD
Bupropion—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00139	0.0026	CcSEcCtD
Bupropion—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00257	CcSEcCtD
Bupropion—Back pain—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00256	CcSEcCtD
Bupropion—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00136	0.00255	CcSEcCtD
Bupropion—SLC6A3—brainstem—amyotrophic lateral sclerosis	0.00135	0.0421	CbGeAlD
Bupropion—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00133	0.00248	CcSEcCtD
Bupropion—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00131	0.00246	CcSEcCtD
Bupropion—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00131	0.00245	CcSEcCtD
Bupropion—Agitation—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00244	CcSEcCtD
Bupropion—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00129	0.00242	CcSEcCtD
Bupropion—CHRNA3—nervous system—amyotrophic lateral sclerosis	0.00128	0.0399	CbGeAlD
Bupropion—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00128	0.00239	CcSEcCtD
Bupropion—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00127	0.00238	CcSEcCtD
Bupropion—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00127	0.00238	CcSEcCtD
Bupropion—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00127	0.00237	CcSEcCtD
Bupropion—SLC6A3—Parkinsons Disease Pathway—ATXN2—amyotrophic lateral sclerosis	0.00125	0.0405	CbGpPWpGaD
Bupropion—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00125	0.00234	CcSEcCtD
Bupropion—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00233	CcSEcCtD
Bupropion—CHRNA3—central nervous system—amyotrophic lateral sclerosis	0.00124	0.0384	CbGeAlD
Bupropion—Cough—Riluzole—amyotrophic lateral sclerosis	0.00123	0.00231	CcSEcCtD
Bupropion—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00123	0.0023	CcSEcCtD
Bupropion—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00229	CcSEcCtD
Bupropion—CHRNA3—cerebellum—amyotrophic lateral sclerosis	0.00121	0.0375	CbGeAlD
Bupropion—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.0012	0.00226	CcSEcCtD
Bupropion—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.0012	0.00226	CcSEcCtD
Bupropion—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.0012	0.00226	CcSEcCtD
Bupropion—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.0012	0.00225	CcSEcCtD
Bupropion—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.0012	0.00224	CcSEcCtD
Bupropion—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00119	0.00223	CcSEcCtD
Bupropion—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00118	0.00221	CcSEcCtD
Bupropion—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00116	0.00218	CcSEcCtD
Bupropion—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00216	CcSEcCtD
Bupropion—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00216	CcSEcCtD
Bupropion—Infection—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00215	CcSEcCtD
Bupropion—Shock—Riluzole—amyotrophic lateral sclerosis	0.00114	0.00213	CcSEcCtD
Bupropion—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00113	0.00212	CcSEcCtD
Bupropion—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00113	0.00212	CcSEcCtD
Bupropion—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00113	0.00211	CcSEcCtD
Bupropion—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00112	0.0021	CcSEcCtD
Bupropion—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00112	0.00209	CcSEcCtD
Bupropion—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.0011	0.00206	CcSEcCtD
Bupropion—SLC6A2—brainstem—amyotrophic lateral sclerosis	0.00109	0.0339	CbGeAlD
Bupropion—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.00108	0.00202	CcSEcCtD
Bupropion—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A1—amyotrophic lateral sclerosis	0.00107	0.0347	CbGpPWpGaD
Bupropion—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00197	CcSEcCtD
Bupropion—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00104	0.00196	CcSEcCtD
Bupropion—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.00104	0.0324	CbGeAlD
Bupropion—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00104	0.00194	CcSEcCtD
Bupropion—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00193	CcSEcCtD
Bupropion—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00192	CcSEcCtD
Bupropion—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00102	0.0019	CcSEcCtD
Bupropion—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.001	0.00188	CcSEcCtD
Bupropion—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000997	0.00187	CcSEcCtD
Bupropion—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000996	0.00187	CcSEcCtD
Bupropion—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000988	0.00185	CcSEcCtD
Bupropion—Pain—Riluzole—amyotrophic lateral sclerosis	0.000988	0.00185	CcSEcCtD
Bupropion—CHRNA3—brain—amyotrophic lateral sclerosis	0.00098	0.0305	CbGeAlD
Bupropion—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000952	0.00178	CcSEcCtD
Bupropion—SLC6A3—Na+/Cl- dependent neurotransmitter transporters—SLC6A1—amyotrophic lateral sclerosis	0.000949	0.0307	CbGpPWpGaD
Bupropion—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000944	0.00177	CcSEcCtD
Bupropion—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000917	0.00172	CcSEcCtD
Bupropion—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000913	0.00171	CcSEcCtD
Bupropion—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000913	0.00171	CcSEcCtD
Bupropion—ORM1—spinal cord—amyotrophic lateral sclerosis	0.000905	0.0281	CbGeAlD
Bupropion—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000851	0.00159	CcSEcCtD
Bupropion—SLC6A3—spinal cord—amyotrophic lateral sclerosis	0.000842	0.0262	CbGeAlD
Bupropion—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000829	0.00155	CcSEcCtD
Bupropion—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000817	0.00153	CcSEcCtD
Bupropion—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00079	0.00148	CcSEcCtD
Bupropion—CYP2A6—cerebellum—amyotrophic lateral sclerosis	0.000788	0.0245	CbGeAlD
Bupropion—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000764	0.00143	CcSEcCtD
Bupropion—ORM1—nervous system—amyotrophic lateral sclerosis	0.000763	0.0237	CbGeAlD
Bupropion—SLC6A2—medulla oblongata—amyotrophic lateral sclerosis	0.000761	0.0237	CbGeAlD
Bupropion—SLC6A2—Amine compound SLC transporters—SLC6A1—amyotrophic lateral sclerosis	0.000744	0.024	CbGpPWpGaD
Bupropion—ORM1—central nervous system—amyotrophic lateral sclerosis	0.000734	0.0228	CbGeAlD
Bupropion—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000734	0.00138	CcSEcCtD
Bupropion—Rash—Riluzole—amyotrophic lateral sclerosis	0.000728	0.00136	CcSEcCtD
Bupropion—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000727	0.00136	CcSEcCtD
Bupropion—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—amyotrophic lateral sclerosis	0.000726	0.0235	CbGpPWpGaD
Bupropion—Headache—Riluzole—amyotrophic lateral sclerosis	0.000723	0.00136	CcSEcCtD
Bupropion—SLC6A3—nervous system—amyotrophic lateral sclerosis	0.000709	0.022	CbGeAlD
Bupropion—SLC6A2—Monoamine Transport—SLC6A1—amyotrophic lateral sclerosis	0.000706	0.0228	CbGpPWpGaD
Bupropion—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000686	0.00129	CcSEcCtD
Bupropion—SLC6A3—central nervous system—amyotrophic lateral sclerosis	0.000683	0.0212	CbGeAlD
Bupropion—SLC6A3—cerebellum—amyotrophic lateral sclerosis	0.000667	0.0207	CbGeAlD
Bupropion—SLC6A3—Amine compound SLC transporters—SLC6A1—amyotrophic lateral sclerosis	0.000659	0.0213	CbGpPWpGaD
Bupropion—CYP2A6—brain—amyotrophic lateral sclerosis	0.00064	0.0199	CbGeAlD
Bupropion—SLC6A3—Monoamine Transport—SLC6A1—amyotrophic lateral sclerosis	0.000626	0.0202	CbGpPWpGaD
Bupropion—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.000598	0.0186	CbGeAlD
Bupropion—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—amyotrophic lateral sclerosis	0.000591	0.0191	CbGpPWpGaD
Bupropion—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.000589	0.019	CbGpPWpGaD
Bupropion—SLC6A2—nervous system—amyotrophic lateral sclerosis	0.000572	0.0178	CbGeAlD
Bupropion—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00057	0.0184	CbGpPWpGaD
Bupropion—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000558	0.0181	CbGpPWpGaD
Bupropion—CYP2D6—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.000552	0.0178	CbGpPWpGaD
Bupropion—SLC6A2—central nervous system—amyotrophic lateral sclerosis	0.000551	0.0171	CbGeAlD
Bupropion—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.000543	0.0176	CbGpPWpGaD
Bupropion—SLC6A3—brain—amyotrophic lateral sclerosis	0.000542	0.0169	CbGeAlD
Bupropion—CYP2E1—medulla oblongata—amyotrophic lateral sclerosis	0.000527	0.0164	CbGeAlD
Bupropion—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.00048	0.0155	CbGpPWpGaD
Bupropion—CYP2E1—spinal cord—amyotrophic lateral sclerosis	0.00047	0.0146	CbGeAlD
Bupropion—CYP1A2—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.000468	0.0151	CbGpPWpGaD
Bupropion—CYP2E1—Vitamin A and Carotenoid Metabolism—RARA—amyotrophic lateral sclerosis	0.000463	0.015	CbGpPWpGaD
Bupropion—CHRNA3—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000442	0.0143	CbGpPWpGaD
Bupropion—SLC6A2—brain—amyotrophic lateral sclerosis	0.000437	0.0136	CbGeAlD
Bupropion—CYP2B6—nervous system—amyotrophic lateral sclerosis	0.000422	0.0131	CbGeAlD
Bupropion—CHRNA3—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000408	0.0132	CbGpPWpGaD
Bupropion—CYP2B6—central nervous system—amyotrophic lateral sclerosis	0.000406	0.0126	CbGeAlD
Bupropion—CYP2E1—nervous system—amyotrophic lateral sclerosis	0.000396	0.0123	CbGeAlD
Bupropion—CHRNA3—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000394	0.0127	CbGpPWpGaD
Bupropion—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000393	0.0127	CbGpPWpGaD
Bupropion—CYP2E1—central nervous system—amyotrophic lateral sclerosis	0.000381	0.0118	CbGeAlD
Bupropion—SLC6A3—Parkinsons Disease Pathway—CASP9—amyotrophic lateral sclerosis	0.000375	0.0121	CbGpPWpGaD
Bupropion—CYP2E1—cerebellum—amyotrophic lateral sclerosis	0.000372	0.0116	CbGeAlD
Bupropion—CHRNA3—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000361	0.0117	CbGpPWpGaD
Bupropion—CYP2C8—brain—amyotrophic lateral sclerosis	0.000359	0.0112	CbGeAlD
Bupropion—CHRNA3—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000339	0.011	CbGpPWpGaD
Bupropion—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000336	0.0109	CbGpPWpGaD
Bupropion—CHRNA3—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000335	0.0108	CbGpPWpGaD
Bupropion—CHRNA3—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000335	0.0108	CbGpPWpGaD
Bupropion—CYP2B6—brain—amyotrophic lateral sclerosis	0.000322	0.01	CbGeAlD
Bupropion—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000318	0.0099	CbGeAlD
Bupropion—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000313	0.00974	CbGeAlD
Bupropion—CHRNA3—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000313	0.0101	CbGpPWpGaD
Bupropion—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000307	0.00953	CbGeAlD
Bupropion—CYP2E1—brain—amyotrophic lateral sclerosis	0.000302	0.0094	CbGeAlD
Bupropion—CHRNA3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000302	0.00977	CbGpPWpGaD
Bupropion—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000302	0.00938	CbGeAlD
Bupropion—CHRNA3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000299	0.00966	CbGpPWpGaD
Bupropion—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000295	0.00916	CbGeAlD
Bupropion—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.000291	0.0094	CbGpPWpGaD
Bupropion—SLC6A2—NRF2 pathway—GSR—amyotrophic lateral sclerosis	0.000286	0.00926	CbGpPWpGaD
Bupropion—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—amyotrophic lateral sclerosis	0.000284	0.00919	CbGpPWpGaD
Bupropion—CHRNA3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000276	0.00893	CbGpPWpGaD
Bupropion—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000259	0.00838	CbGpPWpGaD
Bupropion—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.000258	0.00833	CbGpPWpGaD
Bupropion—CHRNA3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000257	0.00831	CbGpPWpGaD
Bupropion—CHRNA3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000257	0.00831	CbGpPWpGaD
Bupropion—SLC6A3—NRF2 pathway—GSR—amyotrophic lateral sclerosis	0.000254	0.00821	CbGpPWpGaD
Bupropion—CYP2D6—brain—amyotrophic lateral sclerosis	0.000239	0.00744	CbGeAlD
Bupropion—CHRNA3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000229	0.0074	CbGpPWpGaD
Bupropion—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—amyotrophic lateral sclerosis	0.000224	0.00724	CbGpPWpGaD
Bupropion—SLC6A3—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000214	0.00691	CbGpPWpGaD
Bupropion—CYP2A6—NRF2 pathway—GSR—amyotrophic lateral sclerosis	0.000212	0.00685	CbGpPWpGaD
Bupropion—SLC6A2—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.00021	0.00678	CbGpPWpGaD
Bupropion—SLC6A3—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000197	0.00638	CbGpPWpGaD
Bupropion—SLC6A3—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000191	0.00616	CbGpPWpGaD
Bupropion—SLC6A3—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.000186	0.00601	CbGpPWpGaD
Bupropion—SLC6A2—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000174	0.00564	CbGpPWpGaD
Bupropion—SLC6A3—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000174	0.00564	CbGpPWpGaD
Bupropion—SLC6A3—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000164	0.0053	CbGpPWpGaD
Bupropion—SLC6A3—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000162	0.00524	CbGpPWpGaD
Bupropion—SLC6A3—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000162	0.00524	CbGpPWpGaD
Bupropion—SLC6A2—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.000162	0.00523	CbGpPWpGaD
Bupropion—SLC6A3—Parkinsons Disease Pathway—CASP3—amyotrophic lateral sclerosis	0.000158	0.00511	CbGpPWpGaD
Bupropion—CYP2A6—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.000155	0.00502	CbGpPWpGaD
Bupropion—SLC6A3—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000154	0.00499	CbGpPWpGaD
Bupropion—SLC6A3—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000151	0.00489	CbGpPWpGaD
Bupropion—SLC6A2—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000148	0.00479	CbGpPWpGaD
Bupropion—CYP2B6—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000148	0.00478	CbGpPWpGaD
Bupropion—SLC6A3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000146	0.00472	CbGpPWpGaD
Bupropion—CYP2E1—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000145	0.00469	CbGpPWpGaD
Bupropion—CYP2D6—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.000145	0.00467	CbGpPWpGaD
Bupropion—SLC6A3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000144	0.00467	CbGpPWpGaD
Bupropion—SLC6A3—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.000143	0.00463	CbGpPWpGaD
Bupropion—CYP2C8—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000138	0.00448	CbGpPWpGaD
Bupropion—SLC6A2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000138	0.00445	CbGpPWpGaD
Bupropion—SLC6A3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000134	0.00432	CbGpPWpGaD
Bupropion—SLC6A2—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000132	0.00427	CbGpPWpGaD
Bupropion—SLC6A3—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000131	0.00425	CbGpPWpGaD
Bupropion—SLC6A2—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000126	0.00409	CbGpPWpGaD
Bupropion—CYP2C8—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000125	0.00405	CbGpPWpGaD
Bupropion—SLC6A3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000124	0.00401	CbGpPWpGaD
Bupropion—SLC6A3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000124	0.00401	CbGpPWpGaD
Bupropion—CYP1A2—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.000122	0.00396	CbGpPWpGaD
Bupropion—SLC6A3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000122	0.00394	CbGpPWpGaD
Bupropion—CYP2A6—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.00012	0.00387	CbGpPWpGaD
Bupropion—SLC6A3—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000117	0.00379	CbGpPWpGaD
Bupropion—CYP2C9—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000113	0.00364	CbGpPWpGaD
Bupropion—SLC6A3—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000112	0.00362	CbGpPWpGaD
Bupropion—SLC6A3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000111	0.00358	CbGpPWpGaD
Bupropion—CYP2D6—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000103	0.00333	CbGpPWpGaD
Bupropion—CYP2C9—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000102	0.0033	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	9.65e-05	0.00312	CbGpPWpGaD
Bupropion—CYP1A2—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.63e-05	0.00311	CbGpPWpGaD
Bupropion—CYP2A6—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	9.48e-05	0.00307	CbGpPWpGaD
Bupropion—CYP2A6—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	9.36e-05	0.00303	CbGpPWpGaD
Bupropion—SLC6A2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	8.86e-05	0.00287	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	8.82e-05	0.00285	CbGpPWpGaD
Bupropion—CYP1A2—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	8.71e-05	0.00282	CbGpPWpGaD
Bupropion—CYP2A6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	8.21e-05	0.00265	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	8.2e-05	0.00265	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	7.85e-05	0.00254	CbGpPWpGaD
Bupropion—SLC6A3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	7.85e-05	0.00254	CbGpPWpGaD
Bupropion—CYP2C8—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	7.8e-05	0.00252	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	7.71e-05	0.00249	CbGpPWpGaD
Bupropion—SLC6A2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	7.53e-05	0.00244	CbGpPWpGaD
Bupropion—SLC6A2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	7.53e-05	0.00244	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	7.18e-05	0.00232	CbGpPWpGaD
Bupropion—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	6.72e-05	0.00217	CbGpPWpGaD
Bupropion—SLC6A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	6.72e-05	0.00217	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	6.71e-05	0.00217	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	6.68e-05	0.00216	CbGpPWpGaD
Bupropion—SLC6A3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	6.67e-05	0.00216	CbGpPWpGaD
Bupropion—SLC6A3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	6.67e-05	0.00216	CbGpPWpGaD
Bupropion—CYP1A2—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	6.66e-05	0.00215	CbGpPWpGaD
Bupropion—CYP2B6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	6.62e-05	0.00214	CbGpPWpGaD
Bupropion—CYP2B6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	6.53e-05	0.00211	CbGpPWpGaD
Bupropion—CYP2E1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	6.49e-05	0.0021	CbGpPWpGaD
Bupropion—CYP2E1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	6.4e-05	0.00207	CbGpPWpGaD
Bupropion—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	6.35e-05	0.00205	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—TPK1—amyotrophic lateral sclerosis	6.29e-05	0.00203	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—VAPB—amyotrophic lateral sclerosis	6.29e-05	0.00203	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	6.28e-05	0.00203	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	6.14e-05	0.00198	CbGpPWpGaD
Bupropion—SLC6A3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	5.95e-05	0.00192	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	5.8e-05	0.00188	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—VAPA—amyotrophic lateral sclerosis	5.75e-05	0.00186	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	5.7e-05	0.00184	CbGpPWpGaD
Bupropion—CYP2C8—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	5.61e-05	0.00181	CbGpPWpGaD
Bupropion—CYP2C8—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	5.53e-05	0.00179	CbGpPWpGaD
Bupropion—CYP1A2—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	5.43e-05	0.00175	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	5.36e-05	0.00173	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.35e-05	0.00173	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	5.29e-05	0.00171	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—VAPB—amyotrophic lateral sclerosis	5.07e-05	0.00164	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—TPK1—amyotrophic lateral sclerosis	5.07e-05	0.00164	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—FIG4—amyotrophic lateral sclerosis	5.03e-05	0.00163	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—VAPB—amyotrophic lateral sclerosis	4.97e-05	0.00161	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—TPK1—amyotrophic lateral sclerosis	4.97e-05	0.00161	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—VAPA—amyotrophic lateral sclerosis	4.64e-05	0.0015	CbGpPWpGaD
Bupropion—CYP2D6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	4.6e-05	0.00149	CbGpPWpGaD
Bupropion—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	4.57e-05	0.00148	CbGpPWpGaD
Bupropion—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	4.56e-05	0.00148	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—DAO—amyotrophic lateral sclerosis	4.55e-05	0.00147	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—VAPA—amyotrophic lateral sclerosis	4.55e-05	0.00147	CbGpPWpGaD
Bupropion—CYP2D6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	4.54e-05	0.00147	CbGpPWpGaD
Bupropion—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	4.5e-05	0.00145	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.31e-05	0.00139	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	4.3e-05	0.00139	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	4.3e-05	0.00139	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	4.3e-05	0.00139	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.23e-05	0.00137	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—FIG4—amyotrophic lateral sclerosis	4.06e-05	0.00131	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	4.01e-05	0.0013	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—FIG4—amyotrophic lateral sclerosis	3.97e-05	0.00128	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	3.93e-05	0.00127	CbGpPWpGaD
Bupropion—CYP1A2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.9e-05	0.00126	CbGpPWpGaD
Bupropion—CYP1A2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.85e-05	0.00124	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	3.68e-05	0.00119	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—DAO—amyotrophic lateral sclerosis	3.67e-05	0.00119	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.65e-05	0.00118	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—DAO—amyotrophic lateral sclerosis	3.59e-05	0.00116	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	3.53e-05	0.00114	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	3.53e-05	0.00114	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	3.5e-05	0.00113	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	3.5e-05	0.00113	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—PLB1—amyotrophic lateral sclerosis	3.45e-05	0.00111	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	3.43e-05	0.00111	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	3.26e-05	0.00105	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	3.23e-05	0.00104	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	3.2e-05	0.00103	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—GSR—amyotrophic lateral sclerosis	3.18e-05	0.00103	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	3.11e-05	0.001	CbGpPWpGaD
Bupropion—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.01e-05	0.000973	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	3e-05	0.00097	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	2.99e-05	0.000966	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	2.99e-05	0.000966	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.97e-05	0.000961	CbGpPWpGaD
Bupropion—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.97e-05	0.00096	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	2.82e-05	0.000912	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	2.79e-05	0.000904	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.79e-05	0.000901	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—PLB1—amyotrophic lateral sclerosis	2.78e-05	0.000899	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	2.73e-05	0.000883	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—PLB1—amyotrophic lateral sclerosis	2.72e-05	0.00088	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—CHAT—amyotrophic lateral sclerosis	2.61e-05	0.000844	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—GSR—amyotrophic lateral sclerosis	2.57e-05	0.00083	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	2.55e-05	0.000824	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.54e-05	0.000821	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	2.53e-05	0.000817	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—GSR—amyotrophic lateral sclerosis	2.51e-05	0.000813	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	2.39e-05	0.000772	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	2.35e-05	0.000761	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	2.31e-05	0.000745	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	2.31e-05	0.000745	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	2.17e-05	0.000702	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	2.16e-05	0.000698	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	2.11e-05	0.000682	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—CHAT—amyotrophic lateral sclerosis	2.11e-05	0.000681	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—CHAT—amyotrophic lateral sclerosis	2.06e-05	0.000667	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.98e-05	0.00064	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.96e-05	0.000634	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	1.93e-05	0.000625	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	1.92e-05	0.000619	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	1.84e-05	0.000596	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	1.78e-05	0.000577	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	1.78e-05	0.000577	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	1.77e-05	0.000572	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	1.67e-05	0.000539	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	1.64e-05	0.000529	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.63e-05	0.000526	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.61e-05	0.000521	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	1.51e-05	0.000488	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	1.46e-05	0.000473	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	1.45e-05	0.000469	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.4e-05	0.000454	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.38e-05	0.000445	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.32e-05	0.000428	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.29e-05	0.000417	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	1.26e-05	0.000408	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.24e-05	0.000401	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	1.17e-05	0.000377	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.13e-05	0.000366	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.13e-05	0.000366	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.12e-05	0.000361	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.11e-05	0.000359	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—APOE—amyotrophic lateral sclerosis	1.06e-05	0.000343	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.04e-05	0.000336	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.02e-05	0.00033	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.59e-06	0.00031	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	9.57e-06	0.00031	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	9.08e-06	0.000293	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.81e-06	0.000285	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—APOE—amyotrophic lateral sclerosis	8.56e-06	0.000277	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—APOE—amyotrophic lateral sclerosis	8.39e-06	0.000271	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.87e-06	0.000254	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.8e-06	0.000252	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	7.76e-06	0.000251	CbGpPWpGaD
Bupropion—CYP2A6—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.27e-06	0.000235	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	7.25e-06	0.000234	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.23e-06	0.000234	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.17e-06	0.000232	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.67e-06	0.000216	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.13e-06	0.000198	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	5.95e-06	0.000192	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	5.9e-06	0.000191	CbGpPWpGaD
Bupropion—CYP2B6—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.87e-06	0.00019	CbGpPWpGaD
Bupropion—CYP2E1—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.75e-06	0.000186	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.15e-06	0.000166	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	5.04e-06	0.000163	CbGpPWpGaD
Bupropion—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.97e-06	0.000161	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.73e-06	0.000153	CbGpPWpGaD
Bupropion—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.08e-06	0.000132	CbGpPWpGaD
Bupropion—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.04e-06	0.000131	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	3.89e-06	0.000126	CbGpPWpGaD
Bupropion—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.45e-06	0.000112	CbGpPWpGaD
Bupropion—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.67e-06	8.62e-05	CbGpPWpGaD
